Euclidean Technologies Management, LLC Ironwood Pharmaceuticals Inc Transaction History
Euclidean Technologies Management, LLC
- $109 Million
- Q1 2023
A detailed history of Euclidean Technologies Management, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Euclidean Technologies Management, LLC holds 18,475 shares of IRWD stock, worth $116,762. This represents 0.18% of its overall portfolio holdings.
Number of Shares
18,475
Previous 18,475
-0.0%
Holding current value
$116,762
Previous $228,000
14.91%
% of portfolio
0.18%
Previous 0.22%
Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
296Shares Held
170MCall Options Held
27.1MPut Options Held
2.28M-
Black Rock Inc. New York, NY24.2MShares$153 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$123 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$104 Million24.97% of portfolio
-
State Street Corp Boston, MA13.9MShares$88 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA7.21MShares$45.5 Million0.16% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $968M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...